Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Caffeine as an Adjuvant to Opioid Therapy in Cancer Pain: a Randomized, Double-blind, Placebo-controlled Trial

NCT00879775 is registered in ClinicalTrials.gov with Korea Research Foundation as lead sponsor.

NCT NCT00879775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Caffeine as an Adjuvant to Opioid Therapy in Cancer Pain: a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Korea Research Foundation
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2009
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain